The Japan recombinant protein market reached USD 265.7 million in 2024 and is expected to grow at a CAGR of 8.9% during 2025-2033, reaching USD 573.7 million by 2033. Market growth is driven by the expanding development of biopharmaceuticals, including monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly utilized for treating cancer, autoimmune disorders, ... https://www.imarcgroup.com/japan-recombinant-protein-market